Literature DB >> 28757170

The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma.

Massimiliano Cadamuro1, Tommaso Stecca2, Simone Brivio3, Valeria Mariotti4, Romina Fiorotto5, Carlo Spirli5, Mario Strazzabosco6, Luca Fabris7.   

Abstract

Prognosis of cholangiocarcinoma, a devastating liver epithelial malignancy characterized by early invasiveness, remains very dismal, though its incidence has been steadily increasing. Evidence is mounting that in cholangiocarcinoma, tumor epithelial cells establish an intricate web of mutual interactions with multiple stromal components, largely determining the pervasive behavior of the tumor. The main cellular components of the tumor microenvironment (i.e. myofibroblasts, macrophages, lymphatic endothelial cells), which has been recently termed as 'tumor reactive stroma', are recruited and activated by neoplastic cells, and in turn, deleteriously mold tumor behavior by releasing a huge variety of paracrine signals, including cyto/chemokines, growth factors, morphogens and proteinases. An abnormally remodeled and stiff extracellular matrix favors and supports these cell interactions. Although the mechanisms responsible for the generation of tumor reactive stroma are largely uncertain, hypoxia presumably plays a central role. In this review, we will dissect the intimate relationship among the different cell elements cooperating within this complex 'ecosystem', with the ultimate goal to pave the way for a deeper understanding of the mechanisms underlying cholangiocarcinoma aggressiveness, and possibly, to foster the development of innovative, combinatorial therapies aimed at halting tumor progression. This article is part of a Special Issue entitled: Cholangiocytes in Health and Diseaseedited by Jesus Banales, Marco Marzioni, Nicholas LaRusso and Peter Jansen.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer-associated fibroblasts; Extracellular matrix; Lymphatic endothelial cells; Tumor desmoplasia; Tumor-associated macrophages

Mesh:

Year:  2017        PMID: 28757170      PMCID: PMC6386155          DOI: 10.1016/j.bbadis.2017.07.028

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  97 in total

1.  Reconstruction of functionally normal and malignant human breast tissues in mice.

Authors:  Charlotte Kuperwasser; Tony Chavarria; Min Wu; Greg Magrane; Joe W Gray; Loucinda Carey; Andrea Richardson; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

Review 2.  Lymphangiogenesis in development and human disease.

Authors:  Kari Alitalo; Tuomas Tammela; Tatiana V Petrova
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

Review 3.  Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation.

Authors:  B Elenbaas; R A Weinberg
Journal:  Exp Cell Res       Date:  2001-03-10       Impact factor: 3.905

4.  Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line.

Authors:  J Park; L Tadlock; G J Gores; T Patel
Journal:  Hepatology       Date:  1999-11       Impact factor: 17.425

Review 5.  Cholangiocarcinoma.

Authors:  Shahid A Khan; Howard C Thomas; Brian R Davidson; Simon D Taylor-Robinson
Journal:  Lancet       Date:  2005-10-08       Impact factor: 79.321

6.  Transient expression of laminin alpha1 chain in regenerating murine liver: restricted localization of laminin chains and nidogen-1.

Authors:  Yamato Kikkawa; Yoichi Mochizuki; Jeffrey H Miner; Toshihiro Mitaka
Journal:  Exp Cell Res       Date:  2005-04-15       Impact factor: 3.905

7.  The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis.

Authors:  Nils Kinnman; Claire Francoz; Véronique Barbu; Dominique Wendum; Colette Rey; Rolf Hultcrantz; Raoul Poupon; Chantal Housset
Journal:  Lab Invest       Date:  2003-02       Impact factor: 5.662

Review 8.  Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

Authors:  Pia Vihinen; Veli-Matti Kähäri
Journal:  Int J Cancer       Date:  2002-05-10       Impact factor: 7.396

Review 9.  Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis.

Authors:  Yihai Cao
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

10.  Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma.

Authors:  Shin-Ichi Aishima; Ken-Ichi Taguchi; Takahiro Terashi; Shuji Matsuura; Mitsuo Shimada; Masazumi Tsuneyoshi
Journal:  Mod Pathol       Date:  2003-10       Impact factor: 7.842

View more
  14 in total

Review 1.  Cholangiocarcinoma.

Authors:  Paul J Brindley; Melinda Bachini; Sumera I Ilyas; Shahid A Khan; Alex Loukas; Alphonse E Sirica; Bin Tean Teh; Sopit Wongkham; Gregory J Gores
Journal:  Nat Rev Dis Primers       Date:  2021-09-09       Impact factor: 65.038

Review 2.  Precision medicine in cholangiocarcinoma.

Authors:  Antonio Pellino; Fotios Loupakis; Massimiliano Cadamuro; Vincenzo Dadduzio; Matteo Fassan; Maria Guido; Umberto Cillo; Stefano Indraccolo; Luca Fabris
Journal:  Transl Gastroenterol Hepatol       Date:  2018-07-12

Review 3.  Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview.

Authors:  Simone Brivio; Massimiliano Cadamuro; Luca Fabris; Mario Strazzabosco
Journal:  Gene Expr       Date:  2017-10-25

Review 4.  Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.

Authors:  Alphonse E Sirica; Mario Strazzabosco; Massimiliano Cadamuro
Journal:  Adv Cancer Res       Date:  2020-12-09       Impact factor: 6.242

Review 5.  The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma.

Authors:  Oraianthi Fiste; Ioannis Ntanasis-Stathopoulos; Maria Gavriatopoulou; Michalis Liontos; Konstantinos Koutsoukos; Meletios Athanasios Dimopoulos; Flora Zagouri
Journal:  Vaccines (Basel)       Date:  2021-04-22

6.  MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment.

Authors:  Pan Wang; Xinhua Song; Kirsten Utpatel; Runze Shang; Yoon Mee Yang; Meng Xu; Jie Zhang; Li Che; John Gordan; Antonio Cigliano; Ekihiro Seki; Matthias Evert; Diego F Calvisi; Xiaosong Hu; Xin Chen
Journal:  Cell Death Dis       Date:  2019-02-11       Impact factor: 9.685

Review 7.  New insights on the role of vascular endothelial growth factor in biliary pathophysiology.

Authors:  Valeria Mariotti; Romina Fiorotto; Massimiliano Cadamuro; Luca Fabris; Mario Strazzabosco
Journal:  JHEP Rep       Date:  2021-02-04

Review 8.  Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.

Authors:  Alphonse E Sirica; Gregory J Gores; John D Groopman; Florin M Selaru; Mario Strazzabosco; Xin Wei Wang; Andrew X Zhu
Journal:  Hepatology       Date:  2019-03-25       Impact factor: 17.298

Review 9.  The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium.

Authors:  Alessandra Gentilini; Mirella Pastore; Fabio Marra; Chiara Raggi
Journal:  Int J Mol Sci       Date:  2018-09-22       Impact factor: 5.923

10.  Neuropilin-1 is up-regulated by cancer-associated fibroblast-secreted IL-8 and associated with cell proliferation of gallbladder cancer.

Authors:  Chen Chen; Rui Zhang; Li Ma; Qi Li; Ya-Ling Zhao; Guan-Jun Zhang; Dong Zhang; Wen-Zhi Li; Sheng Cao; Lin Wang; Zhi-Min Geng
Journal:  J Cell Mol Med       Date:  2020-09-20       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.